Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
Roswell Park Cancer Institute · with National Cancer Institute (NCI) · NCT07102082
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 160
- US sites recruiting
- 1
- Study start
- September 25, 2025
- Record last updated
- June 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.
Being studied: Modified Risk - None; Modified Risk Claim
Conditions: Smoking Behaviors
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
- Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
- Open to trying a non-combusted oral tobacco product.
- Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
- Have the ability to read, write, and communicate in English.
- Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure
Exclusion Criteria
- Plan to quit smoking in the next 30 days.
- Use of smokeless tobacco at least weekly in the last 6 months.
- Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
- Unwilling or unable to follow protocol requirements.
- Pregnant or planning to become pregnant (by self report)
Recruiting US locations
Roswell Park
Buffalo, NY 14206
Study contacts (from the official record)
- ASK RPCI · 1-800-767-9355 · askroswell@roswellpark.org
Similar studies in New York
All smoking & vaping studies in New York →- RecruitingHealthy volunteersEarly Phase 1
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Roswell Park Cancer Institute
- Location
- Buffalo, NY
- Eligibility basics
- Ages 21+
- RecruitingHealthy volunteers
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Viome
- Location
- New York, NY
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Axsome Therapeutics, Inc.
- Location
- Brooklyn, NY + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Eli Lilly and Company
- Location
- Rochester, NY + 16 other US sites
- Eligibility basics
- Ages 18–75